The Patent Finder

Terms ending in 2034

Cellectis

Every in-force patent on Cellectis's record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,738,289Tevi Chimeric Endonuclease and Their Preferential Cleavage Sites
In force
 · High confidence
Cellectis S.A.In forceHigh confidence
US 10,584,352Methods for Engineering T Cells for Immunotherapy by Using RNA-Guided Cas Nuclease System
In force
 · High confidence
CellectisIn forceHigh confidence
US 10,870,864Methods for Engineering T Cells for Immunotherapy by Using RNA-Guided Cas Nuclease System
In force
 · High confidence
CellectisIn forceHigh confidence
US 11,365,430Methods for Engineering T Cells for Immunotherapy by Using RNA-Guided Cas Nuclease System
In force
 · High confidence
CellectisIn forceHigh confidence
US 9,855,297Methods for Engineering T Cells for Immunotherapy by Using RNA-Guided Cas Nuclease System
In force
 · High confidence
CellectisIn forceHigh confidence
US 9,890,393Methods for Engineering T Cells for Immunotherapy by Using RNA-Guided Cas Nuclease System
In force
 · High confidence
CellectisIn forceHigh confidence
US 10,000,746A Laglidadg Homing Endonuclease Cleaving the T Cell Receptor Alpha Gene and Uses Thereof
In force
 · High confidence
2SEVENTY Bio, Inc.In forceHigh confidence
US 10,006,052A Laglidadg Homing Endonuclease Cleaving the C-C Chemokine Receptor TYPE-5 (CCR5) Gene and Uses Thereof
In force
 · High confidence
2SEVENTY Bio, Inc.In forceHigh confidence
US 11,576,317Mutant Nicotiana Benthamiana Plant or Cell with Reduced Xylt and Fuct
In force
 · High confidence
Cellectis S.A.In forceHigh confidence
US 10,113,162Modifying Soybean Oil Composition Through Targeted Knockout of the FAD2-1A/1B Genes
In force
 · High confidence
CellectisIn forceHigh confidence
6 more term ends in 2034 · Pro
10 of 16 patents shown. Soonest term end first, then patent number.
Pro members see all 16.
Upgrade to Pro
14 of these are in force and held by Cellectis.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited